Europe Smart Inhalers Market

Europe Smart Inhalers Market Size (2023 to 2028)

The size of the Smart Inhalers Market in Europe was worth USD 8.54 million in 2023 and is estimated to be growing at a CAGR of 64.77% to reach USD 103.66 million by 2028. 

The rise in the incidence of respiratory diseases is majorly driving the growth of the market in Europe. Growing focus on developing new devices in the medical sector is straight, elevating the demand for the smart inhalers market. These devices are beneficial for physicians to track their patient’s inhale usage, which is also accelerating the market's growth rate. The growing prevalence of effective treatment procedures and the improvement of the quality of drugs are promoting the market's growth rate in Europe. The easy availability of the devices in pharmaceutical stores and online stores is expanding the size of the market. Smart inhalers are very accurate and promote the best treatment for asthma and chronic obstructive pulmonary diseases. The factor mentioned before is bolstering the demand of the market to the extent in Europe.

Additionally, the rise in air pollution, which causes disorders like asthma and COPD, the inclination of patients towards digitalized medical devices, increasing aging population are further accelerating the market growth. Furthermore, rising awareness about medication, increasing investments in R&D of medical devices, growing respiratory diseases, new product innovations in the pharmaceutical industry, and the technological advancements in the pharma-medical devices industry are driving the Europe Smart Inhalers Market. However, limitations in data privacy, high costs, and lack of availability in many regions are hindering market growth.

This research report on the European smart inhalers market has been segmented and sub-segmented into the following categories:

By Product Type: 

• Nebulizers
• Inhalers

By Disorder: 

• Chronic Obstructive Pulmonary Disease
• Asthma
• Others

By End-user: 

• Patients
• R&D
• Others

By Country: 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

In Europe, the German Smart Inhalers market is positioned top is holding the highest share due to the launch of innovative products with the help of the latest technologies. Furthermore, the growing tendency to improve healthcare services is leveraging the demand of the market. Also, government investments in developing new devices in the medical sector are elevating the growth rate of the European smart inhalers market.

During the forecast period, European countries such as UK, France, Spain, and Italy are expected to register healthy CAGR. The rise in the support from the IT sector in introducing smart inhalers with the sensors attached where a physician can have complete data of the usage of the inhaler by the patient, which will help them do appropriate treatment, is magnifying the demand of the market. In addition, the rise in the scale of pharmaceutical companies in these countries boosts the demand for the smart inhalers market.

KEY MARKET PLAYERS:

A few of the notable companies operating in the European Smart Inhalers Market profiled in this report are Vectura Group plc, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca plc, Adherium Limited, Cohero Health, LLC, Propeller Health, GlaxoSmithKline plc and OPKO Health, Inc.